Filter News
Area of Research
- (-) Isotopes (1)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (1)
- Biology and Environment (8)
- Clean Energy (36)
- Computer Science (1)
- Fusion Energy (2)
- Materials (27)
- Materials for Computing (5)
- National Security (6)
- Neutron Science (16)
- Quantum information Science (3)
- Supercomputing (40)
News Topics
- (-) Biomedical (3)
- (-) Computer Science (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (8)
- Bioenergy (1)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Isotopes (8)
- Materials Science (2)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (24)
- Physics (2)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.